Trial intelligence / Profile preview

Intravenous iron to reduce transfusion in anaemic patients undergoing cardiac surgery

2012-005666-35Phase 4Completed

Sponsor
The Royal Wolverhampton NHS Trust
Start
Apr 2013
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of ferric carboxymaltose in anaemia, sponsored by The Royal Wolverhampton NHS Trust. Started Apr 2013; status: completed.

02

Drugs

ferric carboxymaltose
03

Conditions

anaemia

Beyond the preview

Go deeper on 2012-005666-35.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2012-005666-35.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call